Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
BackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.Method...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eec690c52bbb4f60b59c45289f1ae5ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:eec690c52bbb4f60b59c45289f1ae5ee |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:eec690c52bbb4f60b59c45289f1ae5ee2021-11-30T13:03:01ZAre the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis2234-943X10.3389/fonc.2021.766672https://doaj.org/article/eec690c52bbb4f60b59c45289f1ae5ee2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.766672/fullhttps://doaj.org/toc/2234-943XBackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.MethodsRelevant literatures were retrieved from PubMed, Embase and Web of Science databases according to PRISMA guideline. All relevant parameters were extracted and combined for statistical analysis.ResultsNineteen studies incorporating 3818 MM patients were eventually included in this meta-analysis. 13 studies evaluated that elevated NLR was significantly associated with poor survival outcomes (OS: HR=2.04, P<0.001; PFS: HR=1.96, P=0.003). Elevated NLR was revealed to correlate with ISS stage (ISS III VS I-II, OR=2.23, P=0.003). A total of 7 studies have shown that elevated LMR predicts a better prognosis in MM patients (OS: HR=0.57, P<0.001; PFS: HR=0.49, P<0.05), and two other studies demonstrated that increased MLR was related to poor OS/PFS (OS: HR=1.58, P<0.05; PFS: HR=1.60, P<0.05). However, in the other 6 studies including 1560 patients, the prognostic value of PLR had not been confirmed (OS: HR=0.89, P>0.05; PFS: HR=0.87, P>0.05).ConclusionsThe indexes NLR and LMR/MLR derived from WBCC were validated to be useful biomarkers to predict the prognosis in MM patients, but the evidence of PLR was insufficient.Xinwen ZhangXinwen ZhangJialin DuanJialin DuanZhenyu WenHao XiongHao XiongXiaomin ChenXiaomin ChenYang LiuYang LiuKunyu LiaoKunyu LiaoChunlan HuangChunlan HuangFrontiers Media S.A.articlemultiple myeloma (MM)neutrophil-to-lymphocyte ratio (NLR)platelet-to-lymphocyte ratio (PLR)lymphocyte-to-monocyte ratio (LMR)monocyte-to-lymphocyte ratio (MLR)prognosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
multiple myeloma (MM) neutrophil-to-lymphocyte ratio (NLR) platelet-to-lymphocyte ratio (PLR) lymphocyte-to-monocyte ratio (LMR) monocyte-to-lymphocyte ratio (MLR) prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
multiple myeloma (MM) neutrophil-to-lymphocyte ratio (NLR) platelet-to-lymphocyte ratio (PLR) lymphocyte-to-monocyte ratio (LMR) monocyte-to-lymphocyte ratio (MLR) prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Xinwen Zhang Xinwen Zhang Jialin Duan Jialin Duan Zhenyu Wen Hao Xiong Hao Xiong Xiaomin Chen Xiaomin Chen Yang Liu Yang Liu Kunyu Liao Kunyu Liao Chunlan Huang Chunlan Huang Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis |
description |
BackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.MethodsRelevant literatures were retrieved from PubMed, Embase and Web of Science databases according to PRISMA guideline. All relevant parameters were extracted and combined for statistical analysis.ResultsNineteen studies incorporating 3818 MM patients were eventually included in this meta-analysis. 13 studies evaluated that elevated NLR was significantly associated with poor survival outcomes (OS: HR=2.04, P<0.001; PFS: HR=1.96, P=0.003). Elevated NLR was revealed to correlate with ISS stage (ISS III VS I-II, OR=2.23, P=0.003). A total of 7 studies have shown that elevated LMR predicts a better prognosis in MM patients (OS: HR=0.57, P<0.001; PFS: HR=0.49, P<0.05), and two other studies demonstrated that increased MLR was related to poor OS/PFS (OS: HR=1.58, P<0.05; PFS: HR=1.60, P<0.05). However, in the other 6 studies including 1560 patients, the prognostic value of PLR had not been confirmed (OS: HR=0.89, P>0.05; PFS: HR=0.87, P>0.05).ConclusionsThe indexes NLR and LMR/MLR derived from WBCC were validated to be useful biomarkers to predict the prognosis in MM patients, but the evidence of PLR was insufficient. |
format |
article |
author |
Xinwen Zhang Xinwen Zhang Jialin Duan Jialin Duan Zhenyu Wen Hao Xiong Hao Xiong Xiaomin Chen Xiaomin Chen Yang Liu Yang Liu Kunyu Liao Kunyu Liao Chunlan Huang Chunlan Huang |
author_facet |
Xinwen Zhang Xinwen Zhang Jialin Duan Jialin Duan Zhenyu Wen Hao Xiong Hao Xiong Xiaomin Chen Xiaomin Chen Yang Liu Yang Liu Kunyu Liao Kunyu Liao Chunlan Huang Chunlan Huang |
author_sort |
Xinwen Zhang |
title |
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis |
title_short |
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis |
title_full |
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis |
title_fullStr |
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis |
title_full_unstemmed |
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis |
title_sort |
are the derived indexes of peripheral whole blood cell counts (nlr, plr, lmr/mlr) clinically significant prognostic biomarkers in multiple myeloma? a systematic review and meta-analysis |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/eec690c52bbb4f60b59c45289f1ae5ee |
work_keys_str_mv |
AT xinwenzhang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT xinwenzhang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT jialinduan arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT jialinduan arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT zhenyuwen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT haoxiong arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT haoxiong arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT xiaominchen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT xiaominchen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT yangliu arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT yangliu arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT kunyuliao arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT kunyuliao arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT chunlanhuang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis AT chunlanhuang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis |
_version_ |
1718406599032176640 |